For stroke programs
One partner for
the whole pathway.
Decision support, trial matching and documentation from one partner, licensed by the University of Pittsburgh and built by the NeuroPrecision Lab.
Consistent decisions
Every case checked against the current guideline: 100% concordance across 225 decision points in our benchmark.
Documentation done
The scribe note is ready before the decision is made, for every consultation.
Trials that enroll
TrialLens surfaces every open protocol a patient could enter, before the window closes.
What could it return?
Every figure is yours to change. The defaults are examples, not LUCID results. Missed or delayed stroke care also carries legal risk: recent New York verdicts reached $120M and $40M.
An illustrative estimate from your inputs. LUCID's effect on documentation time and trial enrollment has not been measured in a prospective study.
Three steps to go live.
Your protocols
We map LUCID to your site's stroke protocols and trials.
Your cases
Your clinicians review LUCID on retrospective cases before go-live.
Go live
Training for the team, then LUCID beside every code-stroke call.
See LUCID on your own cases.
A 30-minute walkthrough with the team that built it.